Press Releases

Yourgene Health Launches Insight DPYD Assay

Enhanced pharmacogenetic workflow includes additional variants to support safer, personalised chemotherapy treatment for cancer patients

NGI Becomes First Certified Core Lab and Service Provider for Epigenica’s EpiFinder™ Platforms

Epigenica AB has announced an agreement with the National Genomics Infrastructure, one of the largest technical platforms at SciLifeLab.

Medix Biochemica Announces $5 Million Investment to Expand Recombinant Antigen Capabilities

Medix Biochemica has announced a Board-approved $5 million investment to expand its recombinant antigen and cell culture technology capabilities across its Espoo, Finland and St. Louis, Missouri facilities.

Patients benefit as the Royal Hospital for Neuro-disability introduces innovative predictive technology to support earlier recognition of infection risk

eClinical Solutions and Hobson & Company Quantify Financial and Operational Value of a Clinical Data Intelligence Platform for Clinical Trials

Bringing price transparency to clinical trial technology investment and return, company unveils ROI calculator for pharmaceutical companies and CROs

VisualDx and Perplexity Bring Clinician-Trusted Medical Imagery into Generative AI

START Research Expands Clinical Leadership with Appointment of Dr. Neel Belani as Clinical Investigator at START New Jersey

Strengthening clinical research capabilities in one of the nation’s most densely populated and high-opportunity oncology markets

Revecore Launches AI-Powered Underpayment Recovery and Denial Appeals Capabilities

Axithra Appoints Lars Kongsbak as CEO to Lead Next Phase of Growth and Series A Financing

Axithra today announced the appointment of Lars Kongsbak as Chief Executive Officer.

iProcess Global Research launches AxisOne: the R&D operating system for the world

iProcess Global Research Inc. today announced the launch of AxisOne, an AI-powered platform the company calls the R&D operating system for the world.

ENPICOM Joins the Pistoia Alliance

ENPICOM today announced that it has joined the Pistoia Alliance, the global not-for-profit organization working to lower barriers to innovation in life science and healthcare R&D.

Leinco Technologies and CellCarta Collaborate to Advance Proteomics Solutions and Applications for Drug Development

Leinco Technologies and CellCarta are pleased to announce a strategic collaboration aimed at advancing proteomics solutions that will benefit the development of immuno-oncology and other targeted therapeutic modalities.

Autonomize AI introduces Version 3 of its Intelligence Platform, an AI operating layer for healthcare

Autonomize AI today announced Version 3 of its Autonomize Intelligence Platform, a complete foundation for building, deploying, and governing healthcare-native AI agents at enterprise scale.

Medix Biochemica appoints Petra Furu as Chief Executive Officer

The Board of Directors of Medix Biochemica appoints Petra Furu as Chief Executive Officer of the company, effective 1 June 2026.

Baylor Genetics to Showcase the Impact of Early Genome Sequencing at Annual PLUGS Summit

Baylor Genetics, a leading diagnostic genomics partner offering a full spectrum of comprehensive genetic tests and diagnostic services, today announced it will be participating in the Patient-centered Laboratory Utilization Guidance Services (PLUGS) Summit in Seattle, WA from April 20-21, 2026. The company will also share data about the impact of early genome sequencing in patient care.

Aragen Launches ‘ChemiSHE’, India’s First Women-Led Chemistry Synthesis Laboratory

Aragen Launches ‘ChemiSHE’, India’s First Women-Led Chemistry Synthesis Laboratory

Enhanced Compliance Inc. (ECI) Appoints Khalid Raja as Senior Vice President, Strategic Growth & Advisory

Enhanced Compliance Inc. today announced the appointment of Khalid Raja (Raj) as Senior Vice President, Strategic Growth & Advisory, effective April 13, 2026.

Biognosys Group Announces Collaboration with The Michael J. Fox Foundation to Advance Parkinson’s Disease Research Through the Development of Improved Biomarker Assays

Biognosys Group today announced a major collaboration with The Michael J. Fox Foundation for Parkinson’s Research to advance the development of highly sensitive and quantitative biomarker assays for Parkinson’s disease.

START Strengthens Dallas-Fort Worth Leadership with Dr. Salwan Al Mutar as Director of Clinical Research

Dr. Al Mutar brings deep expertise in gastrointestinal oncology and early-phase clinical trials and will help to expand access to innovative therapies across North Texas.